Regeneron Pharmaceuticals (REGN) had the best month in 2000 by a large-cap US stock in February 2000, returning 369.6%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Regeneron Pharmaceuticals (REGN) | February 2000 | 369.61% |
Incyte (INCY) | February 2000 | 152.52% |
Ciena (CIEN) | February 2000 | 134.16% |
Insmed (INSM) | February 2000 | 128.57% |
Biomarin Pharmaceutical (BMRN) | February 2000 | 117.39% |
Manhattan Associates (MANH) | March 2000 | 102.96% |
Juniper Networks (JNPR) | February 2000 | 101.15% |
Teledyne Technologies (TDY) | March 2000 | 100% |
Intuitive Surgical (ISRG) | July 2000 | 93.58% |
IDEXX Laboratories (IDXX) | February 2000 | 92.45% |
Clean Harbors (CLH) | January 2000 | 89.74% |
Manhattan Associates (MANH) | February 2000 | 88.2% |
Adobe Systems (ADBE) | February 2000 | 82.55% |
NetApp (NTAP) | February 2000 | 81.27% |
Vertex Pharmaceuticals (VRTX) | February 2000 | 77.9% |
Biogen (BIIB) | June 2000 | 77.75% |
Crown (CCK) | December 2000 | 77.62% |
Check Point Software Technologies (CHKP) | February 2000 | 77.53% |
ResMed (RMD) | February 2000 | 74.56% |
Vertex Pharmaceuticals (VRTX) | August 2000 | 74.43% |
NVIDIA (NVDA) | February 2000 | 72.5% |
Analog Devices (ADI) | February 2000 | 69.09% |
Hartford Financial Services (HIG) | March 2000 | 68.8% |
United Therapeutics (UTHR) | June 2000 | 68.68% |
Incyte (INCY) | January 2000 | 68.04% |
Large-cap stocks are treated as having a market cap of $10B+.
